Emerging targets for anticancer vaccination: IDH

por Platten, M., Bunse, L., Wick, W.
Publicado 2021

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma

por Creaney, J, Segal, A, Sterrett, G, Platten, M A, Baker, E, Murch, A R, Nowak, A K, Robinson, B W S, Millward, M J
Publicado 2008

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System

por Abu Hejleh, AP, Huck, K, Jähne, K, Tan, CL, Lanz, TV, Epping, L, Sonner, JK, Meuth, SG, Henneberg, A, Opitz, CA, Herold-Mende, C, Sahm, F, Platten, M, Sahm, K
Publicado 2023

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial

por Wick, A., Sander, A., Koch, M., Bendszus, M., Combs, S., Haut, T., Dormann, A., Walter, S., Pertz, M., Merkle-Lock, J., Selkrig, N., Limprecht, R., Baumann, L., Kieser, M., Sahm, F., Schlegel, U., Winkler, F., Platten, M., Wick, W., Kessler, T.
Publicado 2022